MedPath

HepQuant, LLC

HepQuant, LLC logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

The SHUNT-V Study for Varices

Not Applicable
Completed
Conditions
Chronic Liver Disease
Interventions
Combination Product: HepQuant SHUNT Liver Diagnostic Test
First Posted Date
2018-07-12
Last Posted Date
2025-04-11
Lead Sponsor
HepQuant, LLC
Target Recruit Count
306
Registration Number
NCT03583996
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Methodist Dallas Liver Center, Dallas, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of WA, Seattle, Washington, United States

๐Ÿ‡บ๐Ÿ‡ธ

Accel Research Sites, Orange City, Florida, United States

and more 23 locations

The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology

Phase 2
Terminated
Conditions
NASH - Nonalcoholic Steatohepatitis
Interventions
Combination Product: HepQuant SHUNT Liver Diagnostic Kit
First Posted Date
2017-09-27
Last Posted Date
2021-08-09
Lead Sponsor
HepQuant, LLC
Target Recruit Count
17
Registration Number
NCT03294941
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Virginia Commonwealth University, Richmond, Virginia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Methodist Dallas Medical Center, Dallas, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

TX Digestive Disease Consultants, Dallas, Texas, United States

and more 5 locations

Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124

Early Phase 1
Withdrawn
Conditions
Severe Alcoholic Hepatitis
Interventions
Device: HepQuant SHUNT Test
Drug: Placebo
First Posted Date
2017-03-23
Last Posted Date
2021-08-30
Lead Sponsor
HepQuant, LLC
Registration Number
NCT03087968
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Emory University, Atlanta, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Pennsylvania, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States

and more 9 locations

Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation

Not Applicable
Completed
Conditions
Non-Alcoholic Fatty Liver Disease
Hepatitis C, Chronic
Interventions
Device: Cholate-24-13C (IND 65121) & Cholate-2,2,4,4-d4 (IND 65123)
First Posted Date
2012-04-17
Last Posted Date
2021-07-15
Lead Sponsor
HepQuant, LLC
Target Recruit Count
48
Registration Number
NCT01579162
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Hospital, Aurora, Colorado, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath